Cadre Holdings, Inc. (NYSE:CDRE – Get Free Report) Director Nicolas Sokolow sold 1,095 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $34.10, for a total transaction of $37,339.50. Following the sale, the director now owns 83,208 shares in the company, valued at approximately $2,837,392.80. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Nicolas Sokolow also recently made the following trade(s):
- On Friday, November 22nd, Nicolas Sokolow sold 5,000 shares of Cadre stock. The stock was sold at an average price of $33.25, for a total transaction of $166,250.00.
Cadre Stock Performance
Shares of CDRE stock opened at $33.44 on Thursday. The company has a quick ratio of 1.96, a current ratio of 3.01 and a debt-to-equity ratio of 0.65. The company has a 50 day moving average price of $36.43 and a 200-day moving average price of $34.96. Cadre Holdings, Inc. has a 52 week low of $29.18 and a 52 week high of $40.28. The firm has a market capitalization of $1.36 billion, a PE ratio of 40.28, a P/E/G ratio of 1.98 and a beta of 1.30.
Cadre Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, November 1st were given a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date of this dividend was Friday, November 1st. Cadre’s dividend payout ratio (DPR) is presently 42.17%.
Analysts Set New Price Targets
Separately, Roth Mkm reduced their target price on Cadre from $39.00 to $37.00 and set a “buy” rating for the company in a report on Thursday, November 7th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $39.75.
Read Our Latest Analysis on CDRE
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Cadre by 21.2% during the 1st quarter. Vanguard Group Inc. now owns 1,180,212 shares of the company’s stock valued at $42,724,000 after purchasing an additional 206,564 shares during the last quarter. Loomis Sayles & Co. L P grew its position in Cadre by 21.6% during the third quarter. Loomis Sayles & Co. L P now owns 940,731 shares of the company’s stock valued at $35,701,000 after buying an additional 167,214 shares during the period. Fred Alger Management LLC increased its holdings in Cadre by 87.5% during the third quarter. Fred Alger Management LLC now owns 738,121 shares of the company’s stock valued at $28,012,000 after buying an additional 344,483 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Cadre by 15.1% during the 3rd quarter. Geode Capital Management LLC now owns 583,678 shares of the company’s stock worth $22,155,000 after acquiring an additional 76,750 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Cadre by 32.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 460,500 shares of the company’s stock valued at $16,671,000 after acquiring an additional 113,722 shares during the period. Institutional investors own 43.95% of the company’s stock.
About Cadre
Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.
Featured Articles
- Five stocks we like better than Cadre
- Stock Market Sectors: What Are They and How Many Are There?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Are Dividend Achievers? An Introduction
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Cadre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadre and related companies with MarketBeat.com's FREE daily email newsletter.